Kevin Barber, MD
Ophthalmology · Deland, FLNPI 1184612269
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $47,283 of the $56,250 with a category attached, or 84.1%. 13 manufacturers reported payments, led by Alcon at 36.4% of the total. Reporting peaked in 2024 at $19,976 and has fallen 96.7% since, to $653 in 2025. Among ophthalmology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $370.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$20K
- Glaukos Corporation$18K
- Alcon Research LLC$16K
- Beaver-visitec International, Inc.$700
- NEW World Medical,inc.$439
- AbbVie$345
- plus $200 from 7 others
Across 1,685 payments — averaging $652.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$834K
- Glaukos Corporation$266K
What the payments were for
- Consulting fees$47,28384%
- Speaking & faculty fees$3,7807%
- Travel & lodging$1,6003%
- Food & beverage$3,5416%
- Gifts$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 74 | $20,466 |
| Glaukos Corporation | 6 | $18,394 |
| Alcon Research LLC | 19 | $15,706 |
| Beaver-visitec International, Inc. | 1 | $700 |
| NEW World Medical,inc. | 14 | $439 |
| AbbVie(2 entities) | 27 | $345 |
| Amgen | 3 | $56 |
| Sun Pharmaceutical Industries Inc. | 2 | $44 |
| Sight Sciences, Inc. | 2 | $41 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $22 |
| Smith+Nephew | 1 | $15 |
| Aerie Pharmaceuticals, Inc. | 1 | $11 |
| Rxsight Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iDose$18,201
- NGENUITY$12,367
- ORA$4,550
- AcrySof$3,238
- AcrySof IQ PanOptix$3,035
- Centurion$2,272
- SMART Suite$2,100
- LenSx$1,503
- Luxor$350
- Ahmed Glaucoma Valve$227
- Kahook Dual Blade$227
- AcrySof IQ VIVITY IOL$133
- Streamline Surgical System$118
- ReSTOR$110
- ARGOS$103
- PanOptix$100
- Clareon$100
How this compares
$56,250 in reported general payments places this provider in the 90th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyzultaLatanoprostene Bunod | 14 | $4,348 |
| Prednisolone Acetate | 11 | $306 |
| Latanoprost | 22 | $189 |
| Timolol Maleate | 14 | $109 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Deland
- Cathleen McCabeBradenton$2M
- Daniel KiernanSarasota$1.7M
- David EichenbaumSt Petersburg$1.7M
- Mark MilnerPalm Beach Gardens$1.2M
- Neel DesaiLargo$1M
- Jorge FortunPalm Beach Gardens$798K
- Courtney BoveeTampa$796K
- Harold BrooksTallahassee$683K
- Robert WeinstockLargo$605K
- William TrattlerMiami$579K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.